Cancer and Metastasis Reviews
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 12.7 | Q1 | 92.5% | 3.223 | Q1 | 97.9% |
| 2024 | 8.7 | Q1 | 89.9% | 2.596 | Q1 | 97.1% |
| 2023 | 7.7 | Q1 | 86.5% | 2.866 | Q1 | 97.6% |
| 2022 | 9.2 | Q1 | 86.1% | 2.107 | Q1 | 96.1% |
| 2021 | 9.2 | Q1 | 86.6% | 1.796 | Q1 | 95.1% |
| 2020 | — | — | 2.555 | Q1 | 97.1% | |
| 2019 | — | — | 2.810 | Q1 | 97.5% | |
| 2018 | — | — | 2.427 | Q1 | 96.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1573-7233
ISSN
0167-7659
country
UScoverage
1982-2026